Polmatine – Medicinal Product Register of Latvia

Memantini hydrochloridum

Search by the name of the active substance

Return to the results

Medicinal product name

Polmatine 20 mg film-coated tablets

Pharmaceutical form

Film-coated tablet

Strength

20 mg

Information from the MAH on shortages

No information on expected shortages

Availability of medicinal product

Product No.	Package size	Wholesalers' stock state
13-0179-02	N28	Is available

Legal status

Rx Prescription (Pr.)

Package leaflet

01-04-2021

Summary of product characteristics

01-04-2021

ATC code

N06DX01 – Psychoanaleptics

Medicinal products (12)

Display only medicinal products with a declared price

Display only medicinal products available in wholesalers' stock

Availability of medicinal product	Wholesalers	Package size, content	Primary packaging	Maximum admissible pharmacy price (€ incl. VAT)	Product No.	Labelling
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N14 (20 mg)	PVC/PVDC/Al blister		13-0179-01	Labelling text Apr 1, 2021
Is available (according to the information provided by wholesalers) (79 containers)	Tamro, Magnum Medical, Recipe Plus, Euroaptieka	N28 (20 mg)	PVC/PVDC/Al blister	€ 24.76	13-0179-02	Labelling text Apr 1, 2021
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N42 (20 mg)	PVC/PVDC/Al blister		13-0179-03	Labelling text Apr 1, 2021
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N49: 49 × 1 (20 mg)	PVC/PVDC/Al blister		13-0179-04	Labelling text Apr 1, 2021
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N56 (20 mg)	PVC/PVDC/Al blister		13-0179-05	Labelling text Apr 1, 2021
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N56: 56 × 1 (20 mg)	PVC/PVDC/Al blister		13-0179-06	Labelling text Apr 1, 2021
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N70 (20 mg)	PVC/PVDC/Al blister		13-0179-07	Labelling text Apr 1, 2021
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N84 (20 mg)	PVC/PVDC/Al blister		13-0179-08	Labelling text Apr 1, 2021
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N98 (20 mg)	PVC/PVDC/Al blister		13-0179-09	Labelling text Apr 1, 2021
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N98: 98 × 1 (20 mg)	PVC/PVDC/Al blister		13-0179-10	Labelling text Apr 1, 2021
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N100: 100 × 1 (20 mg)	PVC/PVDC/Al blister		13-0179-11	Labelling text Apr 1, 2021
Not available (according to the information provided by wholesalers)	currently no information on availability from any wholesaler	N112 (20 mg)	PVC/PVDC/Al blister		13-0179-12	Labelling text Apr 1, 2021

Registration information

Marketing authorisation No.	13-0179
Date of authorisation	Aug 23, 2013
Marketing authorisation holder, country	Zaklady Farmaceutyczne Polpharma S.A., Poland

Return to the results

Icon explanation

– Medicine is available
– Medicine is not available
– Distribution permitted for a limited time span
– Without a prescription
– Prescription medicine

– Medicine is listed on the Latvian National Health Service (NHS) list of state reimbursed medicines. (source of the information – the NHS)
– Reference medicine on the NHS List of state reimbursed medicines
– Lowest cost medicine within its therapeutic effectiveness class in cases where no reference medicine is available
- – Next lowest cost medicine after or (in ascending order)

Class A A (green): Suitable for the older persons. The medicinal substance can be used as in younger patients. Changes due to aging do not affect the dose or frequency of administration, and the adverse reaction profile is not different from that of younger patients.

Class B B (grey): There is little research evidence, practical experience or efficacy in older persons.

Class C C (yellow): Suitable for older persons, with specific cautions. The medicinal substance can be used by older persons, but the dose might either have to be reduced, or the frequency of administration decreased due to mild or moderate renal insufficiency or a significant risk of interactions or adverse reactions.

Class D D (red): Avoid use in older persons. Use is possible only in exceptional cases or on a one-off basis. Changes due to aging predispose older persons to adverse or dangerous reactions to the drug. The risk of adverse reactions typically exceeds the benefits.

Meds75+ data source is Finnish Medicines Agency Fimea (licensed under CC BY 4.0).
Data updated on Apr 19, 2024.